Next Article in Journal
Biotechnological Production of Docosahexaenoic Acid Using Aurantiochytrium limacinum: Carbon Sources Comparison And Growth Characterization
Next Article in Special Issue
MytiLec, a Mussel R-Type Lectin, Interacts with Surface Glycan Gb3 on Burkitt’s Lymphoma Cells to Trigger Apoptosis through Multiple Pathways
Previous Article in Journal
The 9th European Conference on Marine Natural Products
Previous Article in Special Issue
Structure of an Amino Acid-Decorated Exopolysaccharide Secreted by a Vibrio alginolyticus Strain
Article

Structure-Activity Relationship Study of the Neuritogenic Potential of the Glycan of Starfish Ganglioside LLG-3

1
Department of Applied Bioorganic Chemistry, Faculty of Applied Biological Sciences, Gifu University, 1-1 Yanagido, Gifu-shi, Gifu 501-1193, Japan
2
Institute for Integrated Cell-Material Sciences (WPI-iCeMS), Kyoto University, Yoshida Ushinomiya-cho, Sakyo-ku, Kyoto 606-8501, Japan
3
Department of Applied Life Science, Faculty of Applied Biological Sciences, Gifu University, 1-1 Yanagido, Gifu-shi, Gifu 501-1193, Japan
*
Authors to whom correspondence should be addressed.
These authors contributed equally to this work. ‡ Synthetic studies on sialoglycoconjugates 162. Part 161: Reference 55.
Academic Editor: Antonio Trincone
Mar. Drugs 2015, 13(12), 7250-7274; https://doi.org/10.3390/md13127062
Received: 30 September 2015 / Accepted: 25 November 2015 / Published: 5 December 2015
(This article belongs to the Special Issue Marine Glycoconjugates)
LLG-3 is a ganglioside isolated from the starfish Linchia laevigata. To clarify the structure-activity relationship of the glycan of LLG-3 toward rat pheochromocytoma PC12 cells in the presence of nerve growth factor, a series of mono- to tetrasaccharide glycan derivatives were chemically synthesized and evaluated in vitro. The methyl group at C8 of the terminal sialic acid residue was crucial for neuritogenic activity, and the terminal trisaccharide moiety was the minimum active motif. Furthermore, the trisaccharide also stimulated neuritogenesis in human neuroblastoma SH-SY5Y cells via mitogen-activated protein kinase (MAPK) signaling. Phosphorylation of extracellular signal-regulated kinase (ERK) 1/2 was rapidly induced by adding 1 or 10 nM of the trisaccharide. The ratio of phosphorylated ERK to ERK reached a maximum 5 min after stimulation, and then decreased gradually. However, the trisaccharide did not induce significant Akt phosphorylation. These effects were abolished by pretreatment with the MAPK inhibitor U0126, which inhibits enzymes MEK1 and MEK2. In addition, U0126 inhibited the phosphorylation of ERK 1/2 in response to the trisaccharide dose-dependently. Therefore, we concluded that the trisaccharide promotes neurite extension in SH-SY5Y cells via MAPK/ERK signaling, not Akt signaling. View Full-Text
Keywords: ganglioside; starfish; neurite outgrowth; PC12 cell; SH-SY5Y cell; structure-activity relationship; MAPK/ERK signaling ganglioside; starfish; neurite outgrowth; PC12 cell; SH-SY5Y cell; structure-activity relationship; MAPK/ERK signaling
Show Figures

Graphical abstract

  • Supplementary File 1:

    default (DOCX, 36 KiB)

MDPI and ACS Style

Yamagishi, M.; Hosoda-Yabe, R.; Tamai, H.; Konishi, M.; Imamura, A.; Ishida, H.; Yabe, T.; Ando, H.; Kiso, M. Structure-Activity Relationship Study of the Neuritogenic Potential of the Glycan of Starfish Ganglioside LLG-3 . Mar. Drugs 2015, 13, 7250-7274. https://doi.org/10.3390/md13127062

AMA Style

Yamagishi M, Hosoda-Yabe R, Tamai H, Konishi M, Imamura A, Ishida H, Yabe T, Ando H, Kiso M. Structure-Activity Relationship Study of the Neuritogenic Potential of the Glycan of Starfish Ganglioside LLG-3 . Marine Drugs. 2015; 13(12):7250-7274. https://doi.org/10.3390/md13127062

Chicago/Turabian Style

Yamagishi, Megumi, Ritsuko Hosoda-Yabe, Hideki Tamai, Miku Konishi, Akihiro Imamura, Hideharu Ishida, Tomio Yabe, Hiromune Ando, and Makoto Kiso. 2015. "Structure-Activity Relationship Study of the Neuritogenic Potential of the Glycan of Starfish Ganglioside LLG-3 " Marine Drugs 13, no. 12: 7250-7274. https://doi.org/10.3390/md13127062

Find Other Styles

Article Access Map by Country/Region

1
Back to TopTop